The Seldinger Files

Chiba needle sharp recanalization for CLTI

A woman in her 90s had pain in her left foot at night and ulcers on the foot that would not heal. Over four weeks they had been getting worse.

Her only risk factor for peripheral arterial disease was her age.

The main artery in her thigh was blocked by a solid wall of calcium, and standard catheters and wires could not get through it. A long needle did. Ten days later the rest pain was gone and the ulcers were nearly healed.

Before
10 days after

Ten days after treatment there is marked improvement in the ulcers and in the appearance of the foot. Rest pain resolved.

Chronic limb-threatening ischemia

Chronic limb-threatening ischemia (CLTI), also known as critical limb ischemia (CLI), is an advanced form of peripheral arterial disease (PAD): a severe blockage of the arteries caused by plaque buildup. CLTI is now the preferred name. It replaced critical limb ischemia to describe ischemia of the leg, too little blood flow, that causes rest pain and ulceration.1 She had both. Important risk factors for PAD include, among others, smoking, diabetes, age, and cardiovascular or cerebrovascular disease, disease of the heart or of the arteries to the brain. Age was her only one.

CLTI reduces blood flow to the foot. It causes pain and ulcers and, if left untreated, can lead to amputation. It is the most severe form of PAD, and almost half of all major leg amputations are the result of it.2,3 Outcomes are poor: in a five-year study of patients with diabetes and CLTI, only 27% of those whose blood flow was restored, and 10% of those whose blood flow was not, were alive with no amputation at all, major or minor, at five years.4

Rest pain is foot pain that comes on when lying flat, and it occurs in patients with severe PAD. It is typically felt in the forefoot, over the metatarsal heads, the ball of the foot.5 It does not occur in the thigh or the calf. Its onset after lying down is very predictable, and it comes essentially every night. It can be confused with other kinds of night pain in the legs, such as restless legs and night leg cramps, and peripheral neuropathy may mask it. Physiologic testing, the ankle-brachial index and the toe-brachial index, confirms the diagnosis.6

The goal of treatment is to improve blood flow, to save the limb and relieve the pain. Every effort must be made to avoid a primary amputation: an amputation as the first treatment, without first trying to restore blood flow. Even when adjusting for demographics, other illnesses and disease severity, primary amputation is associated with lower survival, more secondary amputations and higher healthcare costs.7,8 Recent evidence supports an endovascular-first approach to patients with CLTI, restoring blood flow from inside the artery with catheters and wires.9–11 That is how her blood flow was restored.

Case history

  • Only risk factor for PAD is age
  • Rest pain at night
  • Non-healing ulcerations of the left foot, typical of ischemia
  • Ulcerations worsening over the last 4 weeks

Physiologic evaluation

Non-compressible arteries at the ankle gave a falsely elevated ankle-brachial index (ABI) on the left. Heavily calcified arteries cannot be squeezed shut by the cuff, so the ankle pressure reads high.

The left toe-brachial index (TBI) is severely abnormal, with a flattened pulse volume recording (PVR).

With an ulcer that will not heal, the most crucial step is to determine whether ischemia is present. Physiologic testing, which measures blood flow, should always come before anatomical imaging, which shows the arteries.12 Here the CT angiogram came next.

The ankle reading alone cannot settle the question. The ABI, widely considered the gold standard for detecting PAD, is falsely reassuring, falsely negative, in 30% or even 40% of patients with CLTI.13–17 In a series of 2,226 ABIs, 40% of the patients with limb-threatening ischemia had a normal ABI and a further 20% an inconclusive one, because their ankle arteries could not be compressed.16 An ABI should not be used alone when CLTI is the question: it is not an accurate indicator of blood flow in the foot.16,18 The limit is most evident with medial artery calcification, calcium in the wall of the artery, where the reading can be falsely elevated. Her left ABI of 1.43 is that reading.

Measuring blood flow at the level of the toes is therefore mandatory in CLTI, to improve the detection of significant ischemia,19–22 and the evaluation of a patient with an ulcer must include toe pressures. About 20% of patients tested with an ABI for CLTI have ankle arteries that cannot be compressed, because the tibial arteries are calcified. Among 125 such limbs, all with an ABI of 1.4 or more, a TBI below 0.7 found 89.7% of the occluded or significantly narrowed tibial arteries seen on angiography, against 43.6% for a moderately to severely dampened pulse volume recording.19

Many nuances need to be considered when blood flow in the foot is measured.23,24 The toe-brachial index and the toe systolic pressure should not be confused. The TBI is a screening test for PAD. The toe pressure is the diagnostic test: it shows how low the pressure is at the toe, which bears on whether a wound will heal and on the risk of amputation.23 Her left toe pressure of 33 mmHg and her severely abnormal TBI of 0.20 showed the ischemia that the ankle number hid. How toe pressures are graded is explained on the CLTI page.

Left ABI, falsely elevated
1.43
Left toe pressure
33 mmHg
Left TBI
0.20

CT angiography

  • Diffuse heavy calcification
  • Superficial femoral artery (SFA): multiple severe stenoses, with occlusion at the adductor canal due to a heavily calcified plaque filling the entire lumen of the artery
  • Diffuse tibial artery disease
  • Posterior tibial artery (PTA) entirely occluded
  • Peroneal artery (PA): severe disease
  • Anterior tibial artery (ATA): multiple stenoses, with occlusion at the ankle
  • Pedal artery mostly occluded

Wall of calcium

There was a solid wall of calcium at the distal SFA and the proximal popliteal artery.

A lesion like this can be extremely hard to cross. It often results in an extraluminal crossing, where the wire leaves the true channel of the artery, and a re-entry device may be needed to get back in.

The calcified caps of a chronic total occlusion, the hard ends of a complete blockage, can be very difficult to cross while staying in the lumen, the channel of the artery. Persisting can create a large subintimal space, a channel within the wall of the artery, and a false lumen. Lesions like this often end in a subintimal or extraluminal crossing, which then needs a re-entry device and/or retrograde access, a second approach from below the blockage, to treat the artery successfully.

Angiogram

The angiogram shows a short occlusion of the distal SFA.

Crossing failed with traditional techniques: various crossing catheters, and various .035 and .014 wires. Those images are not shown.

Recanalization

An attempt with the back end of an .014 guidewire was not successful.

The back end of a guidewire is stiffer than its tip, and is sometimes used to break through a hard plaque.

There are two kinds of back end. The back end of an .035 Glide wire, regular or stiff, is relatively blunt and cannot be shaped, and it tends to stay in the lumen. The back end of an .014 or .018 stainless steel wire is sharp and can be shaped, and it ends up outside the lumen more easily. Neither creates a large subintimal space. The back end tried here was an .014, from the second, sharp group, and it did not cross.

Sharp recanalization

A 65 cm 21-gauge Chiba needle was placed through a 40 cm 4F catheter.

Eventually the heavily calcified plaque was crossed.

A Chiba needle is truly sharp. It comes in 20 cm and 65 cm lengths; the 65 cm needle was used here, through the 40 cm catheter. It can be shaped, and it gives 1:1 torque: the tip turns as much as the hub is turned. It has force and penetration power, and it is .035 compatible, so it passes through a catheter made for an .035 wire.

Crossing

After crossing the occlusion, a .014 guidewire was advanced into the peroneal artery.

A CXI .014 crossing catheter was advanced into the peroneal artery, and angiography confirms an intraluminal location: the catheter is inside the true channel of the artery.

Treatment

  • CSI atherectomy
  • Stenting of the popliteal artery
  • Kissing drug-eluting stents (DES) from the distal popliteal artery into the tibioperoneal trunk (TPT) and the ATA
  • Completion angiography shows 2-vessel runoff
  • The distal ATA occlusion was not treated

10 days after treatment

The toe-brachial index, the toe pressure and the first-toe PVR were unchanged. The ankle PVR improved.

The ulcers were nearly healed and the rest pain had resolved.

Before
10 days after

Marked improvement in the ulcers and in the appearance of the foot. Rest pain resolved.

Before
10 days after
Before
10 days after

Discussion

Chiba recanalization

  • Simple, cheap and effective tool for crossing difficult occlusions
  • Can be shaped to allow for directional control
  • Can deliver over a .014/.018 wire and/or through a .035 diagnostic catheter
  • Staying in the true lumen eliminates the need for re-entry devices, or for retrograde access and other time-consuming techniques

Michael Cumming discussed the technique on the BackTable podcast: Chiba Needle Technique for Tough CTO (episode 276, December 2022).

References

  1. Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S–125S.e40. https://doi.org/10.1016/j.jvs.2019.02.016
  2. Varma P, Stineman MG, Dillingham TR. Epidemiology of limb loss. Phys Med Rehabil Clin N Am. 2014;25(1):1–8. https://doi.org/10.1016/j.pmr.2013.09.001
  3. Aboyans V, Ricco JB, Bartelink MEL, et al. Editor's choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(3):305–368. https://doi.org/10.1016/j.ejvs.2017.07.018
  4. Gu Y, Kokar C, Gooday C, Morrow D, Dhatariya K. A 5-year follow-up study to assess clinical outcomes of patients with diabetes undergoing lower limb angiography for significant peripheral artery disease. Diabetes Ther. 2015;6(4):481–493. https://doi.org/10.1007/s13300-015-0131-1
  5. Cranley JJ. Ischemic rest pain. Arch Surg. 1969;98(2):187–188. https://doi.org/10.1001/archsurg.1969.01340080079015
  6. Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(11):e71–e126. https://doi.org/10.1016/j.jacc.2016.11.007
  7. Mustapha JA, Katzen BT, Neville RF, et al. Determinants of long-term outcomes and costs in the management of critical limb ischemia: a population-based cohort study. J Am Heart Assoc. 2018;7(16):e009724. https://doi.org/10.1161/JAHA.118.009724
  8. Duff S, Mafilios MS, Bhounsule P, Hasegawa JT. The burden of critical limb ischemia: a review of recent literature. Vasc Health Risk Manag. 2019;15:187–208. https://doi.org/10.2147/VHRM.S209241
  9. Stavroulakis K, Gkremoutis A, Borowski M, et al. Bypass grafting vs endovascular therapy in patients with non-dialysis-dependent chronic kidney disease and chronic limb-threatening ischemia (CRITISCH registry). J Endovasc Ther. 2020;27(4):599–607. https://doi.org/10.1177/1526602820938465
  10. Okamoto S, Iida O, Takahara M, et al. A Global Vascular Guidelines-based bypass-preferred population and their surgical risk among CLTI patients treated with endovascular therapy in a real-world practice. J Endovasc Ther. 2020;27(4):608–613. https://doi.org/10.1177/1526602820924338
  11. Ni WW, Leong S, Irani F, et al. “Angioplasty-first” approach for limb salvage in Asian patients with critical limb ischemia: outcomes from 3,303 angioplasties on 2,402 limbs in a single tertiary hospital. J Vasc Interv Radiol. 2020;31(12):1969–1977.e1. https://doi.org/10.1016/j.jvir.2020.08.008
  12. Misra S, Shishehbor MH, Takahashi EA, et al. Perfusion assessment in critical limb ischemia: principles for understanding and the development of evidence and evaluation of devices: a scientific statement from the American Heart Association. Circulation. 2019;140(12):e657–e672. https://doi.org/10.1161/CIR.0000000000000708
  13. Rogers RK, Montero-Baker M, Biswas M, Morrison J, Braun J. Assessment of foot perfusion: overview of modalities, review of evidence, and identification of evidence gaps. Vasc Med. 2020;25(3):235–245. https://doi.org/10.1177/1358863X20909433
  14. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med. 2001;18(7):528–532. https://doi.org/10.1046/j.1464-5491.2001.00493.x
  15. Herraiz-Adillo Á, Cavero-Redondo I, Álvarez-Bueno C, Pozuelo-Carrascosa DP, Solera-Martínez M. The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: a systematic review and meta-analysis. Atherosclerosis. 2020;315:81–92. https://doi.org/10.1016/j.atherosclerosis.2020.09.026
  16. AbuRahma AF, Adams E, AbuRahma J, et al. Critical analysis and limitations of resting ankle-brachial index in the diagnosis of symptomatic peripheral arterial disease patients and the role of diabetes mellitus and chronic kidney disease. J Vasc Surg. 2020;71(3):937–945. https://doi.org/10.1016/j.jvs.2019.05.050
  17. Hsu PC, Lee WH, Chen YC, et al. Comparison of different ankle-brachial indices in the prediction of overall and cardiovascular mortality. Atherosclerosis. 2020;304:57–63. https://doi.org/10.1016/j.atherosclerosis.2020.04.005
  18. Tehan PE, Bray A, Chuter VH. Non-invasive vascular assessment in the foot with diabetes: sensitivity and specificity of the ankle brachial index, toe brachial index and continuous wave Doppler for detecting peripheral arterial disease. J Diabetes Complications. 2016;30(1):155–160. https://doi.org/10.1016/j.jdiacomp.2015.07.019
  19. Randhawa MS, Reed GW, Grafmiller K, Gornik HL, Shishehbor MH. Prevalence of tibial artery and pedal arch patency by angiography in patients with critical limb ischemia and noncompressible ankle brachial index. Circ Cardiovasc Interv. 2017;10(5):e004605. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004605
  20. Patry J, Laurencelle L, Bélisle J, Beaumier M. Vascular assessment in patients with a lower limb wound: a correlational study of photoplethysmography and laser Doppler flowmetry toe pressure techniques. J Diabetes Sci Technol. 2022;16(2):470–477. https://doi.org/10.1177/1932296820979973
  21. Babaei MR, Malek M, Rostami FT, Emami Z, Madani NH, Khamseh ME. Non-invasive vascular assessment in people with type 2 diabetes: diagnostic performance of plethysmographic-and-Doppler derived ankle brachial index, toe brachial index, and pulse volume wave analysis for detection of peripheral arterial disease. Prim Care Diabetes. 2020;14(3):282–289. https://doi.org/10.1016/j.pcd.2019.09.005
  22. Laivuori M, Hakovirta H, Kauhanen P, et al. Toe pressure should be part of a vascular surgeon's first-line investigation in the assessment of lower extremity artery disease and cardiovascular risk of a patient. J Vasc Surg. 2021;73(2):641–649.e3. https://doi.org/10.1016/j.jvs.2020.06.104
  23. Trevethan R. Toe systolic pressures and toe-brachial indices: uses, abuses, and shades of gray. Blood Press Monit. 2019;24(2):45–51. https://doi.org/10.1097/MBP.0000000000000372
  24. McAra S, Trevethan R. Measurement of toe-brachial indices in people with subnormal toe pressures: complexities and revelations. J Am Podiatr Med Assoc. 2018;108(2):115–125. https://doi.org/10.7547/16-036